Comparison of mid- to long-term clinical outcomes between anatomical testing and usual care in patients with suspected coronary artery disease: A meta-analysis of randomized trials

被引:2
|
作者
Hwang, In-Chang [1 ,2 ]
Choi, Sol Ji [3 ]
Choi, Ji Eun [3 ]
Ko, Eun-Bi [3 ,4 ]
Suh, Jae Kyung [3 ]
Choi, Insun [3 ]
Kang, Hyun-Jae [1 ,2 ]
Kim, Yong-Jin [1 ,2 ]
Kim, Joo Youn [3 ]
机构
[1] Seoul Natl Univ Hosp, Cardiovasc Ctr, Seoul, South Korea
[2] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea
[3] Natl Evidence Based Healthcare Collaborating Agcy, 173 Toegye Ro, Seoul 04554, South Korea
[4] Yonsei Univ, Dept Hlth Adm, Grad Sch, Wonju, South Korea
关键词
Anatomical Testing; Coronary Artery Disease; Coronary CT Angiography; Functional Testing; Meta-Analysis; ACUTE CHEST-PAIN; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; OPTIMAL MEDICAL THERAPY; CT ANGIOGRAPHY; MYOCARDIAL-PERFUSION; EMERGENCY-DEPARTMENT; DIAGNOSTIC PERFORMANCE; MULTICENTER; IMPACT; COST;
D O I
10.1002/clc.22799
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundControversies remain regarding clinical outcomes following initial strategies of coronary computed tomography angiography (CCTA) vs usual care with functional testing in patients with suspected coronary artery disease (CAD). HypothesisCCTA as initial diagnostic strategy results in better mid- to long-term outcomes than usual care in patients with suspected CAD. MethodsWe searched PubMed, Embase, and Cochrane Library for randomized controlled trials comparing clinical outcomes during 6months' follow-up between initial anatomical testing by CCTA vs usual care with functional testing in patients with suspected CAD. Occurrence of all-cause mortality, nonfatal myocardial infarction (MI), and major adverse cardiovascular events (MACE), and use of invasive coronary angiography and coronary revascularization, were compared between the 2 diagnostic strategies. ResultsTwelve trials were included (20 014 patients; mean follow-up, 20.5months). Patients undergoing CCTA as initial noninvasive testing had lower risk of nonfatal MI compared with those treated with usual care (risk ratio [RR]: 0.70, 95% confidence interval [CI]: 0.52-0.94, P=0.02). There was a tendency for reduced MACE following initial CCTA strategy, but not for risk of all-cause mortality. Compared with functional testing, the CCTA strategy increased use of invasive coronary angiography (RR: 1.53, 95% CI: 1.12-2.09, P=0.007) and coronary revascularization (RR: 1.49, 95% CI: 1.11-2.00, P=0.007). ConclusionsAnatomical testing with CCTA as the initial noninvasive diagnostic modality in patients with suspected CAD resulted in lower risk of nonfatal MI than usual care with functional testing, at the expense of more frequent use of invasive procedures.
引用
收藏
页码:1129 / 1138
页数:10
相关论文
共 50 条
  • [21] Stroke of antiplatelet and anticoagulant therapy in patients with coronary artery disease: a meta-analysis of randomized controlled trials
    Qiao Yu Shao
    Zhi Jian Wang
    Xiao Teng Ma
    Xu Ze Lin
    Liu Pan
    Yu Jie Zhou
    BMC Cardiovascular Disorders, 21
  • [22] Long-term prognostic value of contemporary stress echocardiography in patients with suspected or known coronary artery disease: systematic review and meta-analysis
    Ihekwaba, Ugochukwu
    Johnson, Nicholas
    Choi, Ji Soo
    Savarese, Gianluigi
    Orsini, Nicola
    Khoo, Jeffrey
    Squire, Iain
    Kardos, Attila
    HEART, 2024, 110 (23) : 1349 - 1356
  • [23] Clinical outcomes of stents versus balloon angioplasty in non-acute coronary artery disease - A meta-analysis of randomized controlled trials
    Nordmann, AJ
    Hengstler, P
    Leimenstoll, BM
    Harr, T
    Young, J
    Bucher, HC
    EUROPEAN HEART JOURNAL, 2004, 25 (01) : 69 - 80
  • [24] Mid- and long-term prognosis of off- vs. on-pump coronary artery bypass graft in patients with multisite artery disease
    Le Bivic, Louis
    Magne, Julien
    Blossier, Jean-David
    Piccardo, Alessandro
    Wojtyna, Helene
    Lacroix, Philippe
    Mohty, Dania
    Cornu, Elisabeth
    Le Guyader, Alexandre
    Aboyans, Victor
    JOURNAL OF CARDIOVASCULAR SURGERY, 2019, 60 (03) : 388 - 395
  • [25] Stroke of antiplatelet and anticoagulant therapy in patients with coronary artery disease: a meta-analysis of randomized controlled trials
    Shao, Qiao Yu
    Wang, Zhi Jian
    Ma, Xiao Teng
    Lin, Xu Ze
    Pan, Liu
    Zhou, Yu Jie
    BMC CARDIOVASCULAR DISORDERS, 2021, 21 (01)
  • [26] Percutaneous Coronary Intervention Outcomes in Patients With Stable Obstructive Coronary Artery Disease and Myocardial Ischemia A Collaborative Meta-analysis of Contemporary Randomized Clinical Trials
    Stergiopoulos, Kathleen
    Boden, William E.
    Hartigan, Pamela
    Mobius-Winkler, Sven
    Hambrecht, Rainer
    Hueb, Whady
    Hardison, Regina M.
    Abbott, J. Dawn
    Brown, David L.
    JAMA INTERNAL MEDICINE, 2014, 174 (02) : 232 - 240
  • [27] Long-term clinical outcomes following sirolimus-eluting stent implantation in patients with acute myocardial infarction. A meta-analysis of randomized trials
    Piccolo, Raffaele
    Cassese, Salvatore
    Galasso, Gennaro
    Niglio, Tullio
    De Rosa, Roberta
    De Biase, Chiara
    Piscione, Federico
    CLINICAL RESEARCH IN CARDIOLOGY, 2012, 101 (11) : 885 - 893
  • [28] Safety and efficacy of cervical disc arthroplasty in preventing the adjacent segment disease: a meta-analysis of mid- to long-term outcomes in prospective, randomized, controlled multicenter studies
    Latka, Dariusz
    Kozlowska, Klaudia
    Miekisiak, Grzegorz
    Latka, Kajetan
    Chowaniec, Jacek
    Olbrycht, Tomasz
    Latka, Miroslaw
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2019, 15 : 531 - 539
  • [29] Glycosylated hemoglobin levels and clinical outcomes in nondiabetic patients with coronary artery disease A meta-analysis
    Geng, Jin
    Zhang, Yanchun
    Wang, Bingjian
    Xie, Jun
    Xu, Biao
    Li, Ju
    MEDICINE, 2017, 96 (17)
  • [30] Comparison of an Initial Risk-Based Testing Strategy vs Usual Testing in Stable Symptomatic Patients With Suspected Coronary Artery Disease: The PRECISE Randomized Clinical Trial
    Douglas, Pamela S.
    Nanna, Michael G.
    Kelsey, Michelle D.
    Yow, Eric
    Mark, Daniel B.
    Patel, Manesh R.
    Rogers, Campbell
    Udelson, James E.
    Fordyce, Christopher B.
    Curzen, Nick
    Pontone, Gianluca
    Maurovich-Horvat, Pal
    De Bruyne, Bernard
    Greenwood, John P.
    Marinescu, Victor
    Leipsic, Jonathon
    Stone, Gregg W.
    Ben-Yehuda, Ori
    Berry, Colin
    Hogan, Shea E.
    Redfors, Bjorn
    Ali, Ziad A.
    Byrne, Robert A.
    Kramer, Christopher M.
    Yeh, Robert W.
    Martinez, Beth
    Mullen, Sarah
    Huey, Whitney
    Anstrom, Kevin J.
    Al-Khalidi, Hussein R.
    Vemulapalli, Sreekanth
    JAMA CARDIOLOGY, 2023, 8 (10) : 904 - 914